Skip to content
sellWeak

Kck Ltd. sold $275k of NPCE

owner at NeuroPace Inc. 39,684 shares at an average of $6.92, traded Aug 30, 2024, filed Oct 3, 2024.

Warning score
25
Value
$275k
39,684 shares
Holdings after
5,554,089
-1% from before
From 52-week low
+34%
low $5.90, close $7.92
From 52-week high
-55%
high $17.50, as of Aug 30, 2024

Score components

  • Role
    10% owner
    +12
  • Trade size
    $275k at market
    +13
  • Share of holdings sold
    Sold 0.7% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -9.5%, 3m +66.6%, 6m +87.2%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

NPCEOct 12, 2026 · close 13.00
Since filing Oct 3, 2024: +87.1%SPY +40.2% · excess +46.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001062993-24-017384, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 30, 2024SOpen-market sale
Common Stock
-4,314$7.76$33k5,589,459Oct 3, 2024
Sep 3, 2024SOpen-market sale
Common Stock
-2,093$7.60$16k5,587,366Oct 3, 2024
Sep 4, 2024SOpen-market sale
Common Stock
-14$7.50$1055,587,352Oct 3, 2024
Sep 6, 2024SOpen-market sale
Common Stock
-11$7.50$835,587,341Oct 3, 2024
Sep 13, 2024SOpen-market sale
Common Stock
-1,993$7.59$15k5,585,348Oct 3, 2024
Sep 20, 2024SOpen-market sale
Common Stock
-765$7.50$5,7385,584,583Oct 3, 2024
Sep 23, 2024SOpen-market sale
Common Stock
-282$7.54$2,1265,584,301Oct 3, 2024
Sep 25, 2024SOpen-market sale
Common Stock
-5,858$6.60$39k5,578,443Oct 3, 2024
Sep 26, 2024SOpen-market sale
Common Stock
-5,821$6.62$39k5,572,622Oct 3, 2024
Sep 27, 2024SOpen-market sale
Common Stock
-5,059$6.63$34k5,567,563Oct 3, 2024
Sep 30, 2024SOpen-market sale
Common Stock
-4,749$6.73$32k5,562,814Oct 3, 2024
Oct 1, 2024SOpen-market sale
Common Stock
-4,882$6.77$33k5,557,932Oct 3, 2024
Oct 2, 2024SOpen-market sale
Common Stock
-3,843$6.87$26k5,554,089Oct 3, 2024

Related signals

Other insiders at NeuroPace Inc and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
21Weak
NPCEsell10b5-1
NeuroPace Inc
Martha Morrell
CHIEF MEDICAL OFFICER
$399k
25,000 shares
-33%
37Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$2.7M
168,136 shares
-5%
57Moderate
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$50M
5,270,845 shares
-100%
37Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$1.2M
224,138 shares
-4%
12Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$25k
4,082 shares
-0%
19Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$53k
8,598 shares
-0%
26Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$303k
46,426 shares
-1%
28Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$409k
29,206 shares
-1%
17Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$25k
1,781 shares
-0%
36Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$913k
64,653 shares
-2%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kck Ltd. sold $275k of NPCE | InsiderTell